Skip to main content
logo
IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
30.27
-1.25 (-3.97%)
At close: Feb 13, 2026, 4:00 PM EST
30.87
+0.60 (1.98%)
After-hours: Feb 13, 2026, 5:46 PM EST

IDEAYA Biosciences Revenue

IDEAYA Biosciences had revenue of $207.83M in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to $214.83M, up 5,377.66% year-over-year. In the year 2024, IDEAYA Biosciences had annual revenue of $7.00M, down -70.07%.

Revenue (ttm)
$214.83M
Revenue Growth
+5,377.66%
P/S Ratio
12.43
Revenue / Employee
$1,639,954
Employees
131
Market Cap
2.65B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20247.00M-16.39M-70.07%
Dec 31, 202323.39M-27.55M-54.08%
Dec 31, 202250.93M22.99M82.28%
Dec 31, 202127.94M8.40M43.01%
Dec 31, 202019.54M--
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Apellis Pharmaceuticals1.02B
Catalyst Pharmaceuticals578.20M
Travere Therapeutics435.83M
Tarsus Pharmaceuticals366.10M
Adaptive Biotechnologies276.98M
Viridian Therapeutics70.79M
Beam Therapeutics55.70M
Immunome9.68M
Revenue Rankings

IDYA News

More News